Mereo BioPharma (MREO) Operating Leases (2018 - 2024)
Mereo BioPharma (MREO) posted quarterly Operating Leases of $187000.0 for Q4 2024, down 79.36% year-over-year from $906000.0 in Q1 2024, and down 52.54% quarter-over-quarter from $394000.0 in Q3 2024.
Mereo BioPharma (MREO) Operating Leases (2018 - 2024) Analysis & Trends
Mereo BioPharma (MREO) has reported Operating Leases for 7 consecutive years, with $187000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Operating Leases fell 79.36% year-over-year to $187000.0; the TTM figure through Dec 2024 stood at $187000.0 (down 79.36% YoY), while the FY2024 annual figure was $187000.0, down 79.36% from the prior year.
- Operating Leases slipped to $187000.0 in Q4 2024 per MREO's latest filing, from $394000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $13.9 million in Q2 2020 and bottomed at $187000.0 in Q4 2024.
- Historically, Operating Leases has averaged $2.4 million across 5 years, with a median of $1.4 million in 2022.
- Annual changes were most pronounced in 2020 — Operating Leases plunged 87.24% — and 2021, when it soared 54.63%.
- Mereo BioPharma's Operating Leases stood at $1.5 million in 2020, then jumped by 54.63% to $2.4 million in 2021, then sank by 39.38% to $1.4 million in 2022, then tumbled by 36.79% to $906000.0 in 2023, then tumbled by 79.36% to $187000.0 in 2024.
- Business Quant data shows MREO's Operating Leases at $187000.0 in Q4 2024, $394000.0 in Q3 2024, and $552000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | Mereo BioPharma | 47.73 Mn | 47.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 187,000.00 |
| Sep 30, 2024 | 394,000.00 |
| Jun 30, 2024 | 552,000.00 |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 906,000.00 |
| Jun 30, 2023 | 1.22 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Jun 30, 2022 | 1.83 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Jun 30, 2021 | 2.73 Mn |
| Dec 31, 2020 | 1.53 Mn |
| Jun 30, 2020 | 13.87 Mn |
| Dec 31, 2019 | 11.98 Mn |
| Jun 30, 2019 | 16.90 Mn |
| Dec 31, 2018 | 3.26 Mn |